However, the FDA previously announced in February 2025 that the supply issues related to Ozempic and its weight loss counterpart, Wegovy, have been resolved, effectively decreasing the need for compounded alternatives
pylori infection is more common in people with certain autoimmune diseases, and some research points to H
The controlled composition and sterile preparation allow the solution to be used in experimental protocols requiring high-purity solvent systems
Why does Mounjaro cause diarrhoea
About 20% of patients on GLP-1s have gotten plastic surgery as a result of their weight loss, according to a 2024 survey from the American Society of Plastic Surgeons
But clearly the company is investing heavily into these products, with the hopes of riding one of the biggest waves in modern healthcare: JP Morgan estimates that by 2030, about 10% of Americans will be on GLP-1s